Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Conference item |
| Published: |
Springer
2019
|
| _version_ | 1797073361505878016 |
|---|---|
| author | DiNardo, C Stein, A Stein, E Fathi, A Frankfurt, O Schuh, A Doehner, H Martinelli, G Patel, P Raffoux, E Tan, P Zeidan, A De Botton, S Kantarjian, H Stone, R Lam, D Wang, X Gong, J Kapsalis, S Hickman, D Zhang, V Winkler, T Wu, B Vyas, P |
| author_facet | DiNardo, C Stein, A Stein, E Fathi, A Frankfurt, O Schuh, A Doehner, H Martinelli, G Patel, P Raffoux, E Tan, P Zeidan, A De Botton, S Kantarjian, H Stone, R Lam, D Wang, X Gong, J Kapsalis, S Hickman, D Zhang, V Winkler, T Wu, B Vyas, P |
| author_sort | DiNardo, C |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-06T23:20:59Z |
| format | Conference item |
| id | oxford-uuid:68b7d4ad-7c97-4ca3-a933-7b70cfd37241 |
| institution | University of Oxford |
| last_indexed | 2024-03-06T23:20:59Z |
| publishDate | 2019 |
| publisher | Springer |
| record_format | dspace |
| spelling | oxford-uuid:68b7d4ad-7c97-4ca3-a933-7b70cfd372412022-03-26T18:46:55ZSafety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML)Conference itemhttp://purl.org/coar/resource_type/c_c94fuuid:68b7d4ad-7c97-4ca3-a933-7b70cfd37241Symplectic Elements at OxfordSpringer2019DiNardo, CStein, AStein, EFathi, AFrankfurt, OSchuh, ADoehner, HMartinelli, GPatel, PRaffoux, ETan, PZeidan, ADe Botton, SKantarjian, HStone, RLam, DWang, XGong, JKapsalis, SHickman, DZhang, VWinkler, TWu, BVyas, P |
| spellingShingle | DiNardo, C Stein, A Stein, E Fathi, A Frankfurt, O Schuh, A Doehner, H Martinelli, G Patel, P Raffoux, E Tan, P Zeidan, A De Botton, S Kantarjian, H Stone, R Lam, D Wang, X Gong, J Kapsalis, S Hickman, D Zhang, V Winkler, T Wu, B Vyas, P Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title | Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title_full | Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title_fullStr | Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title_full_unstemmed | Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title_short | Safety and Clinical Activity of Mutant IDH1 Inhibitor IVOSIDENIB (IVO; AG-120) In Combination with AZACITIDINE (AZA) for Newly Diagnosed Acute Myeloid Leukemia (ND AML) |
| title_sort | safety and clinical activity of mutant idh1 inhibitor ivosidenib ivo ag 120 in combination with azacitidine aza for newly diagnosed acute myeloid leukemia nd aml |
| work_keys_str_mv | AT dinardoc safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT steina safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT steine safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT fathia safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT frankfurto safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT schuha safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT doehnerh safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT martinellig safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT patelp safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT raffouxe safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT tanp safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT zeidana safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT debottons safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT kantarjianh safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT stoner safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT lamd safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT wangx safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT gongj safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT kapsaliss safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT hickmand safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT zhangv safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT winklert safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT wub safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml AT vyasp safetyandclinicalactivityofmutantidh1inhibitorivosidenibivoag120incombinationwithazacitidineazafornewlydiagnosedacutemyeloidleukemiandaml |